Ebolosaris Virus

Ebolosaris Virus is a viral infection that attacks several parts of the body. Mainly, it focuses on red blood cells, capillary walls, and nervous cells. It is commonly located in war struck regions of Pesseton and Occidalius.

First Infections
The Pesse-Occidal war caused the spread of this virus. The first people infected were soldiers. They ravished camps so quickly that a single cough placed entire barracks to two week quarantine. It appeared in cities when soldiers came home, then Ebolosaris virus hit epidemic levels. Nearly every nation in the world was hit, many scientists struggled to make the vaccine, since it was spread so easily. Five years after the war, millions were dying from ebolosaris, and seven years after the war, the death count totaled to 2 million people.

Spreading
Ebolosaris Virus is spread by touch, as well as inhalation. This combination, along with a long incubation period causes a high spread risk. There is a high risk (93.7%) of death, and thus, it is very rare to survive. Most often, survivors become carriers of the virus, and have a very high chance of infecting those around them. Ebolosaris virus is especially capable of killing people in nearly all age groups. Most affected are children, the elderly, and those with pre-existing medical conditions. During the Pesse-Occidal War, many people who showed even the early symptoms of ebolosaris virus were quarantined with members of their barracks. The time taken was two weeks, and if symptoms worsened, or it was a full blown outbreak, the entire army was immobilized for nearly a month, and the barrack that had the first symptoms was burned with everyone inside.

Diagnosis
Most simply, ebolosaris virus can be diagnosed by showing symptoms, however, its ability to mimic flu and cold symptoms complicates attempts at diagnosis. Many doctors use the mucus test. A swab of mucus is taken from a patient and analyzed. The test takes about a day, and is 86% accurate. A more accurate test is the Sibons Blood Test, which takes approximately (depending on the sample) two to three days. During that time, the patient is not permitted to leave the hospital. The accuracy of the Sibons Blood Test is approximately 96% accurate. A false positive occurs once in every 800 cases, so, often, two tests are run.

Treatment
During earlier times, there was no treatment, and patients were expected to suffer through until their deaths. Now, an antiviral marketed under Ebolosiks is designed to inhibit viral spread. However, it is only a delay tactic, as it only prolongs the life of the patient by a few days, possibly a week. A recent antiviral was conconcted, and added to annual immunization shots. Now, the disease has once again disappeared, however, there is a fear that excessive contact could cause it to arise again.